Closing the Cancer Care Gap with the Power of Precision Oncology

Cancer is a major global health issue, responsible for about one-sixth of all deaths, surpassing the combined toll of AIDS, tuberculosis, and malaria. It ranks as the top cause of mortality in numerous countries. Technological progress, especially in genomics, has enhanced our grasp of cancer's triggers and fostered precision oncology. In this context, Dr. Marie-Laure Yaspo at ALACRIS Theranostics aims to bridge the care divide with scientifically-backed cancer management methods throughout the patient journey, from prevention to therapy, leveraging MGI's advanced life science tools.